Fujita Gakuen Fujita Medical University (Location: Toyoake City, Aichi Prefecture, Chairman: Kiyotaka Hoshicho) and FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) are using artificial intelligence. We have signed a joint research agreement on the fall prediction system used.

　This prediction system is FRONTEO's artificial intelligence "Concept Encoder (concept encoder)"^®, Concept encoder) ”is an epoch-making system that predicts and presents the risk of falls from nursing records.This time, in collaboration with the Rehabilitation Medicine I course of the Faculty of Medicine of the same university, the fall prediction AI system "Coroban"^®(Patent registration number: Patent No. 6652986), we will work to further improve the accuracy and expand the functions.

　Prior to this joint research agreement, Fujita Medical University Hospital (hospital director: Yukio Yuzawa) and FRONTEO have started a preliminary survey on the performance of "Coroban®" from 2019, and this time, more will be put into practical use. We have decided to start joint research so that medical professionals and patients can use this system with peace of mind.

　FRONTEO will promote research and development of more sophisticated life science AI, aiming for a society that can realize both a healthy and prosperous life in the age of 100 years and a reduction in the burden on the medical field.

　Although the impact of this matter on FRONTEO's business results for the current fiscal year is expected to be minor, we will promptly announce any reasons that should be disclosed in the future.

■ Coroban^®about　URL: https://lifescience.fronteo.com/operations/

Coroban^®Is a fall prediction system that uses the artificial intelligence Concept Encoder, which was developed by FRONTEO together with Eisai Co., Ltd. Concept Encoder reads the electronic medical record and evaluates the risk of falls from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall risk evaluation sheet without increasing the burden on medical staff.Patent registration number: Patent No. 6652986

■ Concept Encoderabout　URL: https://lifescience.fronteo.com/

"Concept Encoder (concept encoder)^®, Concept Encoder) ”is a natural language analysis AI (artificial intelligence) developed by FRONTEO specializing in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. "Concept Encoder" can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ FRONTEOabout　URL: https://www.fronteo.com/

FRONTEO Inc. has developed its own natural language analysis AI (artificial intelligence) engine "KIBIT".^®(Kibit) ”and“ concept encoder^®(Concept encoder) ”is a company that supports information analysis.Established in August 2003 as a company that supports e-discovery (electronic discovery), which preserves evidence, investigates and analyzes electronic data necessary for international proceedings, and digital forensic investigations, and technologies such as an in-house developed data analysis platform To date, we have supported about 8 international proceedings.In addition, we are applying the unique AI-related technology cultivated in the legal business to areas such as life science and business intelligence, and have achieved results in drug discovery research support, diagnostic support, and work style reform. Listed on TSE Mothers on June 1, 2007.The capital is 6 thousand yen (as of March 26, 2,559,206).